{
    "organizations": [],
    "uuid": "10a5c9cbfee953a5f1f28a0ba7574899ab255bf2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sirtex-medical-receives-binding-of/brief-sirtex-medical-receives-binding-offer-from-cdh-idUSFWN1ST07F",
    "ord_in_thread": 0,
    "title": "BRIEF-Sirtex Medical Receives Binding Offer From CDH",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - Sirtex Medical Ltd:\n* ASX ALERT-SIRTEX RECEIVES BINDING OFFER FROM CDH-SRX.AX\n* HAS RECEIVED OFFER CAPABLE OF ACCEPTANCE FROM CDH GENETECH LIMITED FOR ACQUISITION OF ALL OF SHARES IN SIRTEX\n* BOARD OF SIRTEX IS CONSIDERING RELATIVE MERITS AND RISKS OF CDH PROPOSAL AND VARIAN SCHEME\n* WORLDWIDE DOSE SALES FOR PERIOD 1 JANUARY TO 30 APRIL 2018 WERE 3,755, DOWN 10.6% VERSUS PCP\n* NOW ANTICIPATES THAT FY18 UNDERLYING EBITDA WILL BE AT LOWER END OF $75-85 MILLION GUIDANCE PREVIOUSLY ISSUED\n* DIRECTORS OF SIRTEX CONTINUE TO UNANIMOUSLY SUPPORT AND RECOMMEND VARIAN SCHEME\n* SECOND HALF DOSE SALES ARE EXPECTED TO BE RELATIVELY FLAT VERSUS FIRST HALF Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T16:10:00.000+03:00",
    "crawled": "2018-05-23T15:13:36.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sirtex",
        "medical",
        "ltd",
        "asx",
        "receives",
        "binding",
        "offer",
        "received",
        "offer",
        "capable",
        "acceptance",
        "cdh",
        "genetech",
        "limited",
        "acquisition",
        "share",
        "sirtex",
        "board",
        "sirtex",
        "considering",
        "relative",
        "merit",
        "risk",
        "cdh",
        "proposal",
        "varian",
        "scheme",
        "worldwide",
        "dose",
        "sale",
        "period",
        "january",
        "april",
        "versus",
        "pcp",
        "anticipates",
        "fy18",
        "underlying",
        "ebitda",
        "lower",
        "end",
        "million",
        "guidance",
        "previously",
        "issued",
        "director",
        "sirtex",
        "continue",
        "unanimously",
        "support",
        "recommend",
        "varian",
        "scheme",
        "second",
        "half",
        "dose",
        "sale",
        "expected",
        "relatively",
        "flat",
        "versus",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}